You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Litigation Details for In Re Namenda Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in In Re Namenda Direct Purchaser Antitrust Litigation
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for In Re Namenda Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)

Date Filed Document No. Description Snippet Link To Document
2019-03-05 677 United States Patent No. 5,250,534 United States Patent No. 6,469,012 United States Patent No. 644,077 … “red flags.” >! U.S, Patent No. 5,250,534. *1.S, Patent No. 6,469,012. 29 Case 1:15-cv-07488-CM-RWL…the U.S. patent. See Exhibit C, The number of claims in a patent varies from patent to patent. See id.…to a patent holder by a U.S. patent is defined by the issued claims of the patent — the “patented invention… 03/06/19 Page 9 of 220 PATENTING PROCESS A U.S. patent provides the patent holder with the right to External link to document
2019-05-03 710 Memorandum of Law in Opposition to Motion also allowed Forest time to obtain U.S. Patent No. 8,039,009 for Namenda XR, which did not suffer from…fatal flaws of the ’703 patent, and which expired a decade after the ‘703 patent. In a draft letter…from the patent settlements, the desire to preclude additional challenges to the ‘703 patent (i.e., the…Namenda IR to drop their legal challenges to the ’703 Patent and delay launch of generic versions…date three months after the expiration of the ’703 Patent; and (2) using this improperly obtained External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.